SILVER SPRING, MD - Federal advisers Wednesday told the FDA that it should approve Adolor Corp.'s Entereg (alvimopan) for short-term use in hospitalized patients following partial large or small bowel resection surgery with primary anastomosis. (BioWorld Today)